Table 6.
Published reproductive and oncologic outcomes after FST of UTROSCT.
| Study, Year [Ref] | Design | FST Patients (n) |
Age (Median, Range) |
Parity | Surgery | Adjuvant Treatment | Follow Up (Median, Range) |
Recurrence, n (%) | Death, n (%) | Total Pregnancies (n) | ART (n) |
Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Carbone, 2021 [38] | Case series | 2 | 27.5 (25–30) |
NUs: 2 | Dilatation and curretage: 1; Laparotomic myomectomy: 1 | - | 56 (16–96) |
0 | 0 | 2 | 0 | Full-term C-section: 1; Full-term VB: 1 |
ART: assisted reproductive technology; C-section: caesarean section; FST: fertility-sparing treatment; n: number; NU: nulliparous; UTROSCT: uterine tumor resembling ovarian sex cord tumor; VB: vaginal birth.